i0dvpupq | Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/i0dvpupq_hasAnnotation_C4521228>
?:creator	<https://research.tib.eu/covid-19/entity/Bhojwani%2C_Deepa%3B_Sposto%2C_Richard%3B_Shah%2C_Nirali_N.%3B_Rodriguez%2C_Vilmarie%3B_Yuan%2C_Constance%3B_Stetler-Stevenson%2C_Maryalice%3B_O%E2%80%99Brien%2C_Maureen_M.%3B_McNeer%2C_Jennifer_L.%3B_Quereshi%2C_Amrana%3B_Cabannes%2C_Aurelie%3B_Schlegel%2C_Paul%3B_Rossig%2C_Claudia%3B_Dalla-Pozza%2C_Luciano%3B_August%2C_Keith%3B_Alexander%2C_Sarah%3B_Bourquin%2C_Jean-Pierre%3B_Zwaan%2C_Michel%3B_Raetz%2C_Elizabeth_A.%3B_Loh%2C_Mignon_L.%3B_Rheingold%2C_Susan_R.>
?:doi	<https://research.tib.eu/covid-19/entity/10.1038/s41375-019-0426-8>
?:doi	10.1038/s41375-019-0426-8
?:externalLink	<https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608412/>
?:journal	Leukemia
?:license	cc-by
?:pdf_json_files	document_parses/pdf_json/7acdf701829f6ca630581b5465e1f17df052f1c9.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7608412>
?:pmid	<https://research.tib.eu/covid-19/entity/30842605>
?:pmid	30842605
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/7acdf701829f6ca630581b5465e1f17df052f1c9>
?:source	PMC
?:title	Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2019-03-07

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/i0dvpupq>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/i0dvpupq>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all